Beneficient financials
$1.41−0.70%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY26 Mar 31 | FY25 Mar 31 | FY24 Mar 31 |
|---|---|---|---|
| Revenue | $593.0K | $753.0K | $365.0K |
| Gross profit | $593.0K | $753.0K | $365.0K |
| Gross margin | 100.0% | 100.0% | 100.0% |
| Operating income | -$108.0M | -$581.0K | -$2.53B |
| Net income | -$17.7M | $47.9M | -$1.96B |
| Net margin | −2978.2% | 6359.4% | −535852.3% |
| Diluted EPS | $-14.02 | $68.08 | $-5386.48 |
| EBITDA | -$41.3M | -$50.2M | -$118.9M |
| Operating cash flow | -$38.7M | -$37.7M | -$58.2M |
| Free cash flow | -$38.8M | -$38.8M | -$60.0M |
| Diluted shares | 1.3M | 0.7M | 0.4M |
Balance sheet
| Period end | Mar 31 | Mar 31 | Mar 31 |
|---|---|---|---|
| Cash & equivalents | $2.5M | $1.3M | $7.9M |
| Short-term investments | $0.00 | $0.00 | $0.00 |
| Total debt | $96.8M | $117.9M | $120.5M |
| Total assets | $238.8M | $354.9M | $368.5M |
| Total liabilities | $337.5M | $299.3M | $309.6M |
| Shareholders' equity | -$189.3M | -$34.9M | -$192.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology